Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Children's Health

Font Size

New Drug May Treat Muscular Dystrophy

Drug Targets Gene Glitch Seen in Genetic Disorders Including Duchenne Muscular Dystrophy
WebMD Health News
Reviewed by Louise Chang, MD

April 23, 2007 -- An experimental drug called PTC124 may override a gene glitch seen in Duchenne muscular dystrophy and various other genetic disorders.

Duchenne muscular dystrophy is one of nine major forms of muscular dystrophy. It's the most common type of muscular dystrophy in children and affects males.

In Duchenne muscular dystrophy, the muscles decrease in size and grow weaker over time yet may appear larger. Disease progression varies, but many patients need a wheelchair by the time they're 12 years old.

The new drug, called PTC124, isn't available yet, but clinical trials are currently under way.

Today, researchers posted the results from lab tests in mice with a genetic glitch like one seen in a large group of genetic disorders, including Duchenne muscular dystrophy.

The gene glitch hampers the production of dystrophin, a protein needed for muscle development. PTC124 is designed to override that gene glitch, putting dystrophin production back on track.

In lab tests, mice with muscular dystrophy (MD) got PTC124 orally and/or by injection for two to eight weeks.

"Enough dystrophin accumulated in the muscles of the MD mice so that we could no longer find defects in the muscle when we examined them," researcher H. Lee Sweeney, PhD, says in a news release.

Sweeney chairs the University of Pennsylvania's physiology department.

"For all intents and purposes, the disease was corrected by treatment with PTC124" in the mice, Sweeney says.

If PTC124 succeeds in human tests, it may help treat Duchenne muscular dystrophy and similar genetic disorders, note the researchers, who included scientists from PTC Therapeutics, the company that makes PTC124.

The study appears in the advance online edition of Nature.

Today on WebMD

child with red rash on cheeks
What’s that rash?
plate of fruit and veggies
How healthy is your child’s diet?
smiling baby
Treating diarrhea, fever and more.
Middle school band practice
Understanding your child’s changing body.

worried kid
jennifer aniston
Measles virus
sick child

Child with adhd
rl with friends
Syringes and graph illustration